Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Ref-1/APE1 inhibition with novel small molecules blocks ocular neovascularization.

Sardar Pasha SPB, Sishtla K, Sulaiman RS, Park B, Shetty T, Shah F, Fishel ML, Wikel JH, Kelley MR, Corson TW.

J Pharmacol Exp Ther. 2018 Aug 3. pii: jpet.118.248088. doi: 10.1124/jpet.118.248088. [Epub ahead of print]

2.

Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.

Sulaiman RS, Park B, Sheik Pran Babu SP, Si Y, Kharwadkar R, Mitter SK, Lee B, Sun W, Qi X, Boulton ME, Meroueh SO, Fei X, Seo SY, Corson TW.

ACS Chem Biol. 2018 Jan 19;13(1):45-52. doi: 10.1021/acschembio.7b00854. Epub 2017 Dec 1.

PMID:
29193961
3.

Glucocorticoid receptor signaling in the eye.

Sulaiman RS, Kadmiel M, Cidlowski JA.

Steroids. 2018 May;133:60-66. doi: 10.1016/j.steroids.2017.11.002. Epub 2017 Nov 10.

PMID:
29129720
4.

Ferrochelatase is a therapeutic target for ocular neovascularization.

Basavarajappa HD, Sulaiman RS, Qi X, Shetty T, Sheik Pran Babu S, Sishtla KL, Lee B, Quigley J, Alkhairy S, Briggs CM, Gupta K, Tang B, Shadmand M, Grant MB, Boulton ME, Seo SY, Corson TW.

EMBO Mol Med. 2017 Jun;9(6):786-801. doi: 10.15252/emmm.201606561.

5.

Design, synthesis and biological evaluation of photoaffinity probes of antiangiogenic homoisoflavonoids.

Lee B, Sun W, Lee H, Basavarajappa H, Sulaiman RS, Sishtla K, Fei X, Corson TW, Seo SY.

Bioorg Med Chem Lett. 2016 Sep 1;26(17):4277-81. doi: 10.1016/j.bmcl.2016.07.043. Epub 2016 Jul 21.

6.

Kif14 overexpression accelerates murine retinoblastoma development.

O'Hare M, Shadmand M, Sulaiman RS, Sishtla K, Sakisaka T, Corson TW.

Int J Cancer. 2016 Oct 15;139(8):1752-8. doi: 10.1002/ijc.30221. Epub 2016 Jun 24.

7.

A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy.

Sulaiman RS, Merrigan S, Quigley J, Qi X, Lee B, Boulton ME, Kennedy B, Seo SY, Corson TW.

Sci Rep. 2016 May 5;6:25509. doi: 10.1038/srep25509.

8.

A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization.

Sulaiman RS, Quigley J, Qi X, O'Hare MN, Grant MB, Boulton ME, Corson TW.

J Ocul Pharmacol Ther. 2015 Oct;31(8):447-54. doi: 10.1089/jop.2015.0049. Epub 2015 Jun 10.

9.

Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.

Basavarajappa HD, Lee B, Lee H, Sulaiman RS, An H, MagaƱa C, Shadmand M, Vayl A, Rajashekhar G, Kim EY, Suh YG, Lee K, Seo SY, Corson TW.

J Med Chem. 2015 Jun 25;58(12):5015-5027. doi: 10.1021/acs.jmedchem.5b00449. Epub 2015 Jun 16.

10.

Natural product inhibitors of ocular angiogenesis.

Sulaiman RS, Basavarajappa HD, Corson TW.

Exp Eye Res. 2014 Dec;129:161-71. doi: 10.1016/j.exer.2014.10.002. Epub 2014 Oct 7. Review.

11.

The first synthesis of the antiangiogenic homoisoflavanone, cremastranone.

Lee B, Basavarajappa HD, Sulaiman RS, Fei X, Seo SY, Corson TW.

Org Biomol Chem. 2014 Oct 21;12(39):7673-7. doi: 10.1039/c4ob01604a. Epub 2014 Aug 28.

Supplemental Content

Loading ...
Support Center